Reinoud E Knops, Mikhael F El-Chami, Christelle Marquie, Peter Nordbeck, Anne-Floor B E Quast, Roland R Tilz, Tom F Brouwer, Pier D Lambiase, Christopher J Cassidy, Lucas V A Boersma, Martin C Burke, Shari Pepplinkhuizen, Jolien A de Veld, Anouk de Weger, Frank A L E Bracke, Harish Manyam, Vincent Probst, Timothy R Betts, Nick R Bijsterveld, Pascal Defaye, Thomas Demming, Jan Elders, Duncan C Field, Abdul Ghani, Gregory Golovchiner, Jonas S S G de Jong, Nigel Lewis, Eloi Marijon, Claire A Martin, Marc A Miller, Naushad A Shaik, Willeke van der Stuijt, Jürgen Kuschyk, Louise R A Olde Nordkamp, Anita Arya, Alida E Borger van der Burg, Serge Boveda, Dirk J van Doorn, Michael Glikson, Lukas Kaiser, Alexander H Maass, Léon J P M van Woerkens, Amir Zaidi, Arthur A M Wilde, Lonneke Smeding
BACKGROUND: The PRAETORIAN score estimates the risk of failure of subcutaneous implantable cardioverter defibrillator (S-ICD) therapy, using generator and lead positioning on bidirectional chest radiographs. The PRAETORIAN-DFT trial investigates whether PRAETORIAN score calculation is non-inferior to defibrillation testing (DFT), with regard to first shock efficacy in spontaneous events. OBJECTIVE: This pre-specified sub-analysis assesses the predictive value of the PRAETORIAN score for defibrillation success in induced ventricular arrhythmias...
February 7, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society